Fewer Black Veterans Complete Referrals for Lung Cancer Screening

FRIDAY, June 16, 2023 (HealthDay News) -- Black veterans have significantly lower odds of completing lung cancer screening (LCS) than White veterans even after adjusting for demographic and socioeconomic risk factors, according to a study published online June 16 in JAMA Network Open.
Neelima Navuluri, M.D., from the Duke University School of Medicine in Durham, North Carolina, and colleagues examined whether racial disparities in completing lung cancer screening after referral exist within the Durham Veterans Affairs Health Care System. Analysis included 4,562 veterans referred for LCS between July 1, 2013, and Aug. 31, 2021.
The researchers found that 37.1 percent of veterans ultimately completed screening, while 59.3 percent never connected with the LCS program after referral and an informational mailer or telephone call, indicating a critical point in the LCS process. Among Black veterans, screening rates were substantially lower, compared to White veterans (30.5 versus 41.3 percent). When adjusting for demographic and socioeconomic factors, Black veterans had 0.66 times lower odds of screening completion. Risk factors associated with lower odds of screening completion among Black veterans included age, marital status, and current smoking status, while pack-year history, combat veteran status, and care assessment needs were factors associated with higher odds of screening completion.
"These findings can inform qualitative and implementation research to design and assess interventions focused on improving LCS rates among Black veterans," the authors write.
One author disclosed ties to the pharmaceutical industry.
Related Posts
Football Players Face Accelerated Aging
THURSDAY, Dec. 15, 2022 (HealthDay News) -- Retired football players may...
Can Adults Get RSV?
MONDAY, Nov. 7, 2022 (HealthDay News) -- As health experts warn about RSV...
Semaglutide Reduces BMI Category for Adolescents With Obesity
WEDNESDAY, June 7, 2023 (HealthDay News) -- For adolescents with obesity,...
FDA Authorizes Pfizer Booster Shot for Kids Ages 5 to 11
TUESDAY, May 17, 2022 (HealthDay News) -- A single booster dose of the Pfizer...
